Prosecution Insights
Last updated: April 19, 2026

Examiner: RAMADAN, OMAR

Tech Center 1600 • Art Units: 1677 1678

This examiner grants 24% of resolved cases

Performance Statistics

23.5%
Allow Rate
-36.5% vs TC avg
98
Total Applications
+65.9%
Interview Lift
1341
Avg Prosecution Days
Based on 51 resolved cases, 2023–2026

Rejection Statute Breakdown

14.6%
§101 Eligibility
12.5%
§102 Novelty
40.7%
§103 Obviousness
24.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
16972259 DETECTION OF IMMUNE CHECKPOINT MOLECULES BY DEGLYCOSYLATION Non-Final OA Board of Regents, The University of Texas System
17747868 KIT AND METHOD FOR COMBINED DETECTION OF PCT AND PRESEPSIN, AND USE THEREOF Non-Final OA Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
17633292 REDUCE DISCARD OF KIDNEYS FOR TRANSPLANATION AFTER BRAIN DEATH Non-Final OA THE JOHNS HOPKINS UNIVERSITY
19081829 METHOD FOR RAPID IMMUNOHISTOCHEMICAL DETECTION OF AN ANTIGEN FROM A BIOLOGICAL SAMPLE Non-Final OA Marc Key
18571904 Means and Methods for Selection of Specific Binders Non-Final OA Vrije Universiteit Brussel
17423939 DETECTION OF CEREBROSPINAL FLUID Final Rejection Gwangju Institute of Science and Technology
18054823 ANALYSIS, SCREENING, AND SELECTION FOR SOLUBLE PROTEIN FUNCTION IN SECRETED PROTEIN CELL LIBRARIES Non-Final OA University of Kansas
17298646 FUNCTIONAL SCREEN FOR SMALL MOLECULE AND MONOCLONAL ANTIBODY DRUG SENSITIVITY IN MULTIPLE MYELOMA PATIENTS Final Rejection The Regents of the University of Colorado, a body corporate
17435439 DRIED REAGENT POLYSACCHARIDE SURFACE AREA STABILIZATION Final Rejection Siemens Healthcare Diagnostics Inc.
18614506 COMPOSITIONS, METHODS AND SYSTEMS FOR PROTEIN CORONA ANALYSIS AND USES THEREOF Final Rejection Seer, Inc.
17099190 ASSAY PANELS Non-Final OA Meso Scale Technologies, LLC.
18548262 BIOELECTRONIC SYSTEM FOR RARE CELL SEPARATION AND APPLICATION THEREOF Non-Final OA Yu-Sheng HSIAO
17702107 DEVICE AND METHOD FOR DETECTING INFLAMMATION Final Rejection INNOTECH PRECISION MEDICINE, INC.
17818802 Method and reagents for the detection of an autoantibody Non-Final OA Institució Catalana de Recerca i Estudis Avançats (ICREA)
16471105 BINDING ASSAY Non-Final OA Immutep S.A.S.
17416197 THERAPY GUIDANCE AND/OR THERAPY MONITORING FOR A TREATMENT WITH ANGIOTENSIN-RECEPTOR-AGONIST AND/OR A PRECURSOR THEREOF Non-Final OA 4TEEN4 PHARMACEUTICALS GMBH
17611351 Reagents and Methods for Cancer Detection, Prognosis, and Therapeutic Monitoring Final Rejection INANOVATE, INC.
17770025 APPARATUSES AND METHODS FOR DETECTION OF PANCREATIC CANCER Non-Final OA RECCAN AB
17684193 MOUSE MONOCLONAL ANTIBODIES AGAINST GALACTOSE-DEFICIENT IGA1,PREPARATION METHOD THEREOF, AND USE THEREOF Non-Final OA National Defense Medical Center
17615693 BIOMARKERS FOR PULMONARY EMBOLISM IN EXHALED BREATH CONDENSATE Non-Final OA Aalborg Universitet
17415248 PARTICLE BASED SMALL MOLECULE-PROTEIN COMPLEX TRAP Final Rejection Orionis Biosciences BV
17440620 Postural Orthostatic Tachycardia Syndrome and CRTH2 Final Rejection Amerimmune, LLC
17471513 METHODS FOR CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS Final Rejection UAB Research Foundation
17438306 IN VITRO METHOD FOR OBTAINING CLINICAL DATA IN PATIENTS SUFFERING FROM AN INFLAMMATORY DISEASE Final Rejection FUNDACIÓN PARA LA FORMACIÓN E INVESTIGACIÓN SANITARIAS DE LA REGIÓN DE MURCIA (FFIS)
17279064 TAILORED LAYERS OF CELLULOSE DISPERSIONS FOR DETECTING ANALYTES Final Rejection Fraunhfer-Gesellschaft zur Förderung der angewandten Forschung e.V.
16479827 MAGNETIC PARTICLE-BASED IMMUNOASSAY AND METHODS OF USING THE SAME Final Rejection CONFER HEALTH, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month